Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Factor VII for the Conservative Management Trials of Intractable Postpartum Haemorrhage: is it a Drug Effect , Operator Experience or Inherent Result of the Aetiology.

NCT05298826 is registered in ClinicalTrials.gov with Aljazeera Hospital as lead sponsor.

NCT NCT05298826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Factor VII for the Conservative Management Trials of Intractable Postpartum Haemorrhage: is it a Drug Effect , Operator Experience or Inherent Result of the Aetiology.
Lead sponsor
Aljazeera Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
January 10, 2020
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post partum hemorrhage